NCT05331872View on ClinicalTrials.gov

Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

August 30, 2022

Study Completion Date

September 30, 2023

Conditions
Liver Cirrhosis
Interventions
BIOLOGICAL

Human umbilical cord-derived mesenchymal stem cell infusion

Human umbilical cord-derived mesenchymal stem cell infusion in the management of adult liver cirrhosis

Trial Locations (1)

100000

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi

All Listed Sponsors
lead

Vinmec Research Institute of Stem Cell and Gene Technology

OTHER

NCT05331872 - Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis | Biotech Hunter | Biotech Hunter